Volociximab (M200) is an IgG4 monoclonal antibody targeting the alpha5beta1 integrin , with antiangiogenic, antitumor and anticancer activity, inhibits the growth of rabbit VX2 tumors and is used to study solid tumors.
CAS Number:
[558480-40-3]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted